Biotech Turning Heads For Second Time This Week

Biotech Turning Heads For Second Time This Week

By: Tomas Ronolski - AllPennyStocks.com News

Thursday, August 18, 2022

This biotech company seems to hog the spotlight as of late. We covered a release earlier this week pertaining to a stock buyback program the company is initiating. Now the Austin-based micro cap is at it again after the company announced that it was awarded $17.6 million in grants form the state of Texas. This sent shares of Plus Therapeutics Inc. (Nasdaq:PSTV) soaring during Thursday’s premarket.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.

As mentioned, traders are bullish on the news as shares are currently bid up at $1.09/share (+96.42% implied open for sellers) right before the opening bell. This should be an exciting session!


Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Canadian Inflation Moves Up as Expected But Easing Underlying Pressures Boost Hopes of June Rate Cut
Mixed Shelf Filing Gives Micro Cap Delayed Boost
Key Executive Appointment Sends Small Cap Higher
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top